[Podcast] The Empowered Patient, implications for healthcare delivery

Publish date:

Covid-19 is profoundly and rapidly shifting healthcare delivery.

Before Covid-19, people booked in-person appointments with doctors. Tests were carried out in hospitals. Now, as seen in some countries and localities, people are avoiding medical facilities and doctors are performing more diagnoses by telephone and video calls. Some people are feeling more empowered to search for assessments and treatments online, while others are avoiding medical facilities and doctors’ offices entirely.

People are increasingly interested in digital health technologies to access proper care and manage their health. Life sciences companies and healthcare providers are launching innovations to meet this demand – from telemedicine and connected devices to virtual trials and fitness and wellness apps. Different technologies have been cobbled together during the pandemic to meet the surge in demand for low-touch and touchless care. For many, their home is the new point of care.

A recent Capgemini survey asked people how their attitudes towards healthcare have changed in 2020. The results: “The empowered patient” will have a profound impact for pharmaceutical companies, payers, healthcare providers, medical devices manufacturers, technology companies, regulators, and of course, the patient themselves.

Listen to Capgemini’s Eliza Silvester, SAP’s John Murray and Capgemini’s Marisa Slatter for their take on The Empowered Patient: Implications for Healthcare Delivery.

Related Resources

Life Sciences

The Health Fix – the debate

How the pandemic has transformed views on health and digital health services and what this...

Life Sciences

Digital Patient Engagement

Insights for the Pharmaceutical Industry